Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT06947993 ·Status: RECRUITING ·Phase: PHASE2

A Study for HSK44459 in Participants With Atopic Dermatitis

NCT06996912 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis

NCT00703573 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT06397911 ·Status: RECRUITING ·Phase: PHASE2

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT04875169 ·Status: COMPLETED ·Phase: PHASE3

The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis

NCT04839380 ·Status: COMPLETED ·Phase: PHASE2

KM110329 in Adult Patients With Atopic Dermatitis

NCT01692093 ·Status: UNKNOWN ·Phase: PHASE2

The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis

NCT05186922 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of LW402 in Moderate-to-Severe Atopic Dermatitis

NCT07186387 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

NCT04413942 ·Status: UNKNOWN ·Phase: PHASE2

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

NCT03091426 ·Status: COMPLETED ·Phase: PHASE2

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

NCT04893941 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

NCT03568162 ·Status: COMPLETED ·Phase: PHASE2

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis

NCT03689829 ·Status: TERMINATED ·Phase: PHASE1

Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)

NCT00914186 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis

NCT07015762 ·Status: RECRUITING ·Phase: PHASE1

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

NCT05117060 ·Status: COMPLETED ·Phase: PHASE2

A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis

NCT05265923 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

NCT07230483 ·Status: RECRUITING ·Phase: PHASE2

A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis

NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT05999799 ·Status: TERMINATED ·Phase: PHASE2

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

NCT04805411 ·Status: COMPLETED ·Phase: PHASE2